Benchling

On a mission to unlock the power of biotechnology and empower our global customers to get to milestones & market faster.

Founded 2012

San Francisco, United States 813 employees Series F+ Total: $411.13M Biotechnology, Life Sciences

General Information

Company Name Benchling

Founded Year 2012

Location

San Francisco, United States

Founders / Decision Makers

Employees 813

Industries Biotechnology, Life Sciences

Funding Stage Series F+

Business Model B2B, SaaS, Platform

Revenue Model Subscription, Usage Based, Service Fee

Hiring 30 roles posted in the month to 31 Oct 2026

Offices as of Oct 2026

San Francisco, United States Boston, United States Zurich, Switzerland Belfast, United Kingdom

Social

BounceWatch is an independent company data service, not affiliated with Benchling. To contact Benchling, visit benchling.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Benchling compare?

A PDF of Benchling and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Benchling soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Tech Stack Change Oct 30, 2026

Added Amplitude to their site.

Product Launch Oct 30, 2026

Benchling launched BenchBench-Cloning, a new benchmark evaluating AI models on molecular cloning tasks.

Event Participation Oct 28, 2026

Benchling's Jason Boyd spoke at the Lab of the Future event about data challenges facing development teams.

Homepage Update Oct 28, 2026

Significant changes detected on company website (85.4% content change).

Actively Hiring Oct 27, 2026

Hiring for 30 positions in the last 30 days.

Feature Release Oct 26, 2026

Benchling launched a new AI-powered Western blot annotator feature that allows users to generate annotations by describing what they need.

+2 more signals in last 30 days

Get alerts when Benchling shows new signals

About Benchling

Benchling, founded in 2012, is at the forefront of transforming the biotechnology and life sciences sectors. Headquartered in the United States, this innovative platform is redefining biotech R&D for the AI era with a mission to unlock the power of biotechnology, enabling global customers to reach milestones faster.

The company's platform serves as an AI-driven solution that integrates seamlessly into research workflows, allowing scientists to design experiments, capture structured data, and operate AI agents and models. Its impact is significant, with over 200,000 scientists from academic labs to major players like Sanofi and Moderna relying on Benchling.

Benchling's recent funding achievements include a substantial $100.00M Series F investment on 1 November 2021, backed by prominent investors Lone Pine Capital, Altimeter Capital, Franklin Templeton, and Tiger Global. Such backing underscores the platform's promise in reshaping the future of biotech R&D through data-driven and AI-enhanced solutions.

Business keywords: R&D Acceleration, Scientific Data Management, Life Sciences Software, Experiment Design, Biopharma Research, Cloud Applications, CRISPR, CAR-T Immunotherapy, Genetic Engineering, AI-Powered Research, Workflow Automation, Biotech Innovation, Data-Driven Science

Services & Products

Predictive Models Connection

Experiment Design and Analysis

Data Management and Capture

Workflow Automation

Software and AI Integration

Custom App Development

Scientific Data Modeling

Target Customers

Scientists Biopharma Companies Research Teams R&D Departments Industrial Biotech Firms Agritech Innovators Academic Institutions

Pricing

as listed on Sep 29, 2026

On request

Benchling's pricing page

Funding Rounds & Investors (9)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Series F	$100.00M	4	Lone Pine Capital, Altimeter Capital +2	01 Nov 2021
Series E	$200.00M	12	Lux Capital, Benchmark +10	01 Apr 2021
Series D	$50.00M	2	Alkeon Capital, Iconiq Growth	01 May 2020
Series C	$34.50M	5	Y Combinator, Benchmark +3	01 Jul 2019
Series B	$14.50M	3	Benchmark, F-Prime Capital +1	01 Jun 2018
Series A	$7.00M	1	Thrive Capital	01 Oct 2016
Seed	$5.00M	3	Andreessen Horowitz/ a16z, Thrive Capital +1	01 Apr 2015
Seed	$130.00K	1	Y Combinator	01 Sep 2014
Support Program	Undisclosed	1	Y Combinator	01 Jul 2012

Latest News

View All

Benchling brings goal-driven AI agent teams to the lab with Science Foundries

R&D World Oct 15, 2026

Benchling launches Science Foundries, a new way for scientists and agents to work together

PR Newswire Oct 15, 2026

Benchling launches Direct Data Share, Closing the Loop Between the Lab and the AI Data Cloud on Snowflake

Yahoo Finance Oct 15, 2026

Sanofi forms cloud partnership with Benchling

Tech Jun 12, 2024

Reshape wants to help ‘decode nature’ by automating the ‘visual’ part of lab experiments

Techcrunch Apr 09, 2024

Benchling Alternatives & Competitors

View All Alternatives

Benchling vs

Synthace United Kingdom

Helping scientists solve the world's most pressing problems with faster, more powerful experiments.

Series C

36 employees

Automation, Biotechnology

Compare Benchling vs Synthace

Benchling vs

Automata United Kingdom

Where legacy ends, Automata begins.

Series C

167 employees

AI, Biotechnology

Compare Benchling vs Automata

Benchling vs

OrganoTherapeutics Luxembourg

Using Midbrain Organoids for the development of new Therapeutics against Parkinson`s Disease.

9 employees

Biopharma, Biotechnology

Also compare with:

Ozette View all alternatives

FAQ About Benchling

On a mission to unlock the power of biotechnology and empower our global customers to get to milestones & market faster.

Benchling was founded in 2012.

Benchling is headquartered in San Francisco, United States. As of Oct 2026, it also has offices in Boston, United States, Zurich, Switzerland and Belfast, United Kingdom.

Benchling operates in Biotechnology and Life Sciences. Its work centres on R&D Acceleration, Scientific Data Management, Life Sciences Software and Experiment Design. Its customers include Scientists, Biopharma Companies and Research Teams.

Benchling has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Usage Based and Service Fee.

As listed on Benchling's pricing page on Sep 29, 2026: On request.

Benchling has approximately 813 employees.

Benchling has completed 9 funding rounds, raising a total of $411.13M. The latest funding stage is Series F+.

Benchling offers: Predictive Models Connection, Experiment Design and Analysis, Data Management and Capture, Workflow Automation, Software and AI Integration, Custom App Development, Scientific Data Modeling.

Top alternatives and competitors to Benchling include Synthace, Automata, OrganoTherapeutics, Dianox, Synthego. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Benchling and Synthace are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Benchling, https://bouncewatch.com/company/benchling, updated 12 October 2026. When citing, please name BounceWatch and link this page.

Benchling

General Information

Discover More

What changed at Benchling recently?

About Benchling

Services & Products

Target Customers

Pricing

Funding Rounds & Investors (9)

Latest News

Benchling Alternatives & Competitors

FAQ About Benchling